Krebs Biochem Reports Strong Financial Growth in Half Yearly Results
Krebs Biochem has reported a positive growth in operating profit, net profit, and EPS for the half yearly period, with a return on capital employed of 12.19% and a healthy debt to equity ratio of 0.02. However, MarketsMojo has given a 'Strong Sell' call for the company's stock, indicating caution for potential investors.
Operating Profit - Half Yearly: At Rs 3.05 cr has Grown at 22.37 % Year on Year (YoY).Near term profit trend is positive.Net Profit - Half Yearly: At Rs 1.55 cr has Grown at 23.08 % Year on Year (YoY).Near term profit trend is positive.EPS - Half Yearly: At Rs 0.45 has Grown at 25.00 % Year on Year (YoY).Near term EPS trend is positive.
ROCE: Return on Capital Employed for the quarter Mar 2024 stands at 12.19 %, an improvement from the previous quarter's 11.11 %.
Debt to Equity Ratio: The company has maintained a healthy debt to equity ratio of 0.02, indicating a low level of debt and a strong financial position.
Overall, Krebs Biochem has shown steady growth in its financial performance for the quarter Mar 2024. However, MarketsMOJO has given a 'Strong Sell' call for the company's stock, indicating caution for potential investors. It is important to note that this is not a recommendation from experts or investors, but rather a neutral assessment based on the company's financial data. As a microcap company in the pharmaceutical industry, Krebs Biochem may face challenges in the highly competitive market. Investors should carefully consider all factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
